Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease

[1]  C. Weiller,et al.  Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms , 2022, Brain : a journal of neurology.

[2]  A. Schulze-Bonhage,et al.  Gray-White Matter Blurring of the Temporal Pole Associated With Hippocampal Sclerosis: A Microstructural Study Involving 3 T MRI and Ultrastructural Histopathology. , 2021, Cerebral cortex.

[3]  Indrajeet Patil,et al.  performance: An R Package for Assessment, Comparison and Testing of Statistical Models , 2021, J. Open Source Softw..

[4]  Michel Rijntjes,et al.  Approximation to pain‐signaling network in humans by means of migraine , 2020, Human brain mapping.

[5]  M. McKeown,et al.  Serotonergic System Impacts Levodopa Response in Early Parkinson's and Future Risk of Dyskinesia , 2020, Movement disorders : official journal of the Movement Disorder Society.

[6]  S. Aoki,et al.  NODDI in clinical research , 2020, Journal of Neuroscience Methods.

[7]  K. Van Laere,et al.  Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease , 2020, Movement disorders : official journal of the Movement Disorder Society.

[8]  R. Cilia,et al.  Natural history of motor symptoms in Parkinson’s disease and the long-duration response to levodopa , 2020, Brain : a journal of neurology.

[9]  B. Mollenhauer,et al.  Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide , 2020, Movement disorders clinical practice.

[10]  Jianfeng Feng,et al.  Automated anatomical labelling atlas 3 , 2020, NeuroImage.

[11]  E. Tobias,et al.  The Levodopa Response Varies in Pathologically Confirmed Parkinson's Disease: A Systematic Review , 2020, Movement disorders clinical practice.

[12]  Tanya Simuni,et al.  Neurite orientation dispersion and density imaging (NODDI) and free‐water imaging in Parkinsonism , 2019, Human brain mapping.

[13]  W. Oertel,et al.  Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals? , 2019, Movement disorders : official journal of the Movement Disorder Society.

[14]  C. Verney,et al.  Human Motor Thalamus Reconstructed in 3D from Continuous Sagittal Sections with Identified Subcortical Afferent Territories , 2018, eNeuro.

[15]  K. Jellinger,et al.  Lateralisation in Parkinson disease , 2018, Cell and Tissue Research.

[16]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[17]  Gerta Rücker,et al.  18F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment , 2017, The Journal of Nuclear Medicine.

[18]  B. Mollenhauer,et al.  Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa Cohort , 2017, Movement disorders clinical practice.

[19]  Ofer Pasternak,et al.  Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study , 2017, Movement disorders : official journal of the Movement Disorder Society.

[20]  A. Strafella,et al.  Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts , 2017, Translational Neurodegeneration.

[21]  Jürgen Hennig,et al.  Disentangling micro from mesostructure by diffusion MRI: A Bayesian approach , 2017, NeuroImage.

[22]  M. Tomiyama,et al.  What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum? , 2016, Front. Neurosci..

[23]  Jelle Veraart,et al.  Diffusion MRI noise mapping using random matrix theory , 2016, Magnetic resonance in medicine.

[24]  Luca Mainardi,et al.  Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease , 2016, Front. Aging Neurosci..

[25]  Osamu Abe,et al.  Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease , 2016, European Radiology.

[26]  K. Jellinger,et al.  Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis , 2016, Neurology.

[27]  Thomas W. McAllister,et al.  Age effects and sex differences in human brain white matter of young to middle-aged adults: A DTI, NODDI, and q-space study , 2016, NeuroImage.

[28]  J. Tanabe,et al.  Microstructural Changes within the Basal Ganglia Differ between Parkinson Disease Subtypes , 2016, Front. Neuroanat..

[29]  A. Cherubini,et al.  Alterations of putaminal shape in de novo Parkinson's disease , 2016, Movement disorders : official journal of the Movement Disorder Society.

[30]  Günther Deuschl,et al.  MDS research criteria for prodromal Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[31]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[32]  T. Jovin,et al.  Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons , 2015, Cell Death and Disease.

[33]  Jan Booij,et al.  The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review , 2015, EJNMMI Research.

[34]  D. Vaillancourt,et al.  Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study , 2015, Neurobiology of Aging.

[35]  Bibek Dhital,et al.  Gibbs‐ringing artifact removal based on local subvoxel‐shifts , 2015, Magnetic resonance in medicine.

[36]  H. Shill,et al.  Low clinical diagnostic accuracy of early vs advanced Parkinson disease , 2014, Neurology.

[37]  Yi Su,et al.  Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques , 2013, Annals of neurology.

[38]  C. Adler,et al.  Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. , 2013, Brain : a journal of neurology.

[39]  T. Videen,et al.  Validation of nigrostriatal positron emission tomography measures: Critical limits , 2013, Annals of neurology.

[40]  Daniel C. Alexander,et al.  NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain , 2012, NeuroImage.

[41]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[42]  Susanne Pirker,et al.  Dopamine transporter imaging in autopsy‐confirmed Parkinson's disease and multiple system atrophy , 2012, Movement disorders : official journal of the Movement Disorder Society.

[43]  S. Muramatsu,et al.  Subregional 6-[18F]fluoro-ʟ-m-tyrosine Uptake in the Striatum in Parkinson's Disease , 2011, BMC neurology.

[44]  R. Burke,et al.  Clinical progression in Parkinson disease and the neurobiology of axons , 2010, Annals of neurology.

[45]  Satoshi Orimo,et al.  Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease , 2008 .

[46]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[47]  A. Bonnet,et al.  Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. , 2006, Archives of neurology.

[48]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[49]  D. Brooks.  Dopamine agonists: their role in the treatment of Parkinson's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.

[50]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[51]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[52]  G. E. Alexander,et al.  Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.

[53]  J. Penney,et al.  The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.

[54]  A J Lees,et al.  Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[55]  OUP accepted manuscript , 2022, Brain.

[56]  Meenakshi Singh,et al.  Current and Emerging Concepts , 2014 .

[57]  A. Kakita,et al.  Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. , 2008, Brain : a journal of neurology.

[58]  Ariel Y Deutch,et al.  Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism. , 2007, Parkinsonism & related disorders.

[59]  Joseph E Parisi,et al.  Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. , 2002, Archives of neurology.

[60]  A. Gupta,et al.  A Bayesian Approach to , 1997 .